Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
NCT04496453 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2023-04-18
Summary
The purpose of this study is to develop and evaluate a tool designed to help parents make decisions about childhood vaccines.
Conditions
- Vaccine Refusal
Interventions
- OTHER
-
Childhood vaccination decision support tool
Participants receive childhood vaccination decision support tool
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Center for Advancing Translational Sciences (NCATS)
collaborator NIH - lead OTHER
Principal Investigators
-
Lavanya Vasudevan, Ph.D. · Duke University
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-14
- Primary Completion
- 2022-03-24
- Completion
- 2022-03-24
Countries
- United States
Study Locations
More Related Trials
-
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
NCT00467519 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing Delay in Vaccination of Children: Logistic Barriers
NCT03516682 ·Status: COMPLETED ·Phase: NA
-
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957 ·Status: COMPLETED ·Phase: NA
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004799 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States
NCT05040802 ·Status: COMPLETED
-
An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
NCT00870350 ·Status: UNKNOWN ·Phase: PHASE4
-
Adolescent Vaccination Reminder Study
NCT01732315 ·Status: COMPLETED ·Phase: NA
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of BCG on TDaP-IPV Vaccination
NCT02771782 ·Status: UNKNOWN ·Phase: PHASE4
-
4 Pillars Toolkit for Adolescent Vaccination
NCT02165722 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
NCT00524732 ·Status: COMPLETED
-
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
NCT00802867 ·Status: COMPLETED ·Phase: PHASE4
-
Pertussis Vaccine in Healthy Pregnant Women
NCT00707148 ·Status: COMPLETED ·Phase: PHASE1
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers
NCT07213089 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants
NCT02477995 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
NCT06344065 ·Status: RECRUITING ·Phase: PHASE3
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004800 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
NCT01311557 ·Status: COMPLETED ·Phase: PHASE4
-
Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®
NCT00319553 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children
NCT05870618 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
NCT00514059 ·Status: COMPLETED ·Phase: PHASE4
-
Pertussis Acellular Vaccine Adjuvanted With TQL1055
NCT04793620 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
NCT00662870 ·Status: COMPLETED ·Phase: PHASE3